glp-1 fatty liver disease Why are agonists being used to treat patients with nonalcoholic disease? Revolutionizing MASLD treatment with GLP-1

Getting refills too early creates stockpile that might expire before you use it

Geographic variation and risk factor association of early versus late onset colorectal cancer

Fraser (@iamfra5er), who recently did a quick breakdown of my journey online, pointed out something very true

Therefore, the choice of clinical treatment needs to be weighed against a variety of factors, including efficacy, safety, and individual patient differences, to develop a better treatment plan for subsequent diagnosis and treatment

Labs (In-House or Through Your PCP) Labs can be completed with your PCP or with us

On the other hand, 20% of the Ozempic trial participants felt nausea, and 10% indicated instances of vomiting , both of which are common symptoms associated with gastroparesis